drugset

drugset / Trial / NCT00583115

Safety Study of Gleevec® in Children With Pulmonary Hypertension

NCT00583115 ↗

Phase 2 Terminated 1 enrolled Indiana University

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to find out if the drug, Gleevec, is safe and effective in treating children with Pulmonary Hypertension.

Timeline

Start: 2007-10
Primary completion: 2013-08
Completion: 2013-12

Outcome

Outcome not reported

Stopped (Enrollment): “Unable to enroll subjects”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Imatinib	Small molecule	260 mg/m2	Oral

Indications